Skip to content
Many US acute care hospitals have seen an increase in healthcare-associated infections (HAIs)—including serious drug-resistant threats—in 2021, in “contrast with the success in reducing […]
CDC reports significant rise in healthcare-associated infections Read More »
Saturday’s Adaptation and Agriculture Day at COP27, which focused on the need for food systems innovation (including biotech) to feed 8 billion people, conveyed
COP27: Adaptation is essential for tackling global food security Read More »
Christopher A. Viehbacher has been named president and chief executive officer of Biogen Inc. as well as a member of the board of directors,
Biogen appoints Christopher Viehbacher as CEO and president Read More »
Regenerative farming is not only beneficial for soil and crops “but also improves the nutritional value of conventionally grown plant and animal foods,” but
Regenerative farming must ‘triple’ to limit climate change, SMI report says Read More »
A new biotech company says they can reverse the aging process in living cells by “flipping” DNA markers, helping us stay healthier longer, according
Biotech firm chasing ‘fountain of rejuvenation’ Read More »
A new, cross-sectional study on the prevalence of post-acute sequelae of SARS CoV-2 infection shows that women are almost twice as likely to experience
Women are twice as likely to have long COVID, says new research Read More »
There is a chance to safeguard a national symbol by weighing in on a gene-edited American chestnut trees immune to blight. The U.S. Department
USDA seeks input on gene-edited American chestnut tree Read More »
A letter from 178 CFOs representing major corporations urges legislative leaders to overturn a change in the tax code that would limit deductions for
CFOs oppose tax change that kills R&D incentives Read More »
Climate change has already had a massive impact on crops and agriculture, but the health care sector is bracing itself for an onslaught of
Climate change exacerbates infectious diseases, studies find Read More »
BIO member Pfizer Inc.’s antiviral drug Paxlovid, which has already been shown to reduce the risk of hospitalization and death from COVID-19, can also
Paxlovid reduces the risk of long COVID, says study Read More »
